Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950142-25-000298·Hathaway John Jason
Schedule 13G ownership disclosure
MEDICUS PHARMA LTD
Common shares, no par value · CUSIP: 58471K202
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- John Hathaway
Shares: 800,952.00 · Class: 6.8%
- SkinJect Partners LLC
Shares: 800,952.00 · Class: 6.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950142-25-000298
- Form type
- SCHEDULE 13G
- Filer
- Hathaway John Jason
- CIK
- CIK 2054587
- Filed
- Feb 10, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership